Terns Pharmaceuticals, Inc. (TERN)
NASDAQ: TERN · Real-Time Price · USD
29.36
+2.23 (8.22%)
At close: Dec 5, 2025, 4:00 PM EST
29.11
-0.25 (-0.85%)
After-hours: Dec 5, 2025, 7:56 PM EST
Terns Pharmaceuticals Market Cap
Terns Pharmaceuticals has a market cap or net worth of $2.64 billion as of December 5, 2025. Its market cap has increased by 426.85% in one year.
Market Cap
2.64B
Enterprise Value
2.35B
1-Year Change
426.85%
Ranking
Category
Stock Price
$29.36
Market Cap Chart
Since the IPO on February 5, 2021, Terns Pharmaceuticals's market cap has increased from $143.61M to $2.64B, an increase of 1,741.61%. That is a compound annual growth rate of 82.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 2.64B | 462.04% |
| Dec 31, 2024 | 470.56M | 17.33% |
| Dec 29, 2023 | 401.05M | -20.44% |
| Dec 30, 2022 | 504.08M | 182.17% |
| Dec 31, 2021 | 178.64M | 24.39% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |